Trial Condition(s):

Acute Bacterial Sinusitis

Treatment of patients with acute sinusitis

Bayer Identifier:

12803

ClinicalTrials.gov Identifier:

NCT00930488

EudraCT Number:

Not Available

Study Completed

Trial Purpose

For each patient, an initial visit and at least one follow-up visit at the end of treatment should be documented by the treating physician in the case report form.

Inclusion Criteria
- Any patient with a diagnosis of acute bacterial sinusitis treated with Avelox® - in accordance with the local production information.
Exclusion Criteria
- Those specified in the local product information - contraindications and precautions must be considered.

Trial Summary

Enrollment Goal
6777
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Avelox (Moxifloxacin hydrochloride, BAY12-8039)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, United Arab Emirates

Status
Completed
 
Locations

Investigative Site

Many Locations, China

Status
Completed
 
Locations

Investigative Site

Many Locations, Kuwait

Status
Completed
 
Locations

Investigative Site

Many Locations, Lebanon

Status
Completed
 
Locations

Investigative Site

Many Locations, Malaysia

Status
Completed
 
Locations

Investigative Site

Many Locations, Romania

Status
Completed
 
Locations

Investigative Site

Many Locations, Singapore

Status
Completed
 
Locations

Investigative Site

Many Locations, Yemen

Status
Completed
 
Locations

Investigative Site

Many Locations, Germany

Status
Completed
 
Locations

Investigative Site

Many Locations, Austria

Status
Completed
 
Locations

Investigative Site

Many Locations, Bahrain

Status
Completed
 
Locations

Investigative Site

Many Locations, Egypt

Status
Completed
 
Locations

Investigative Site

Many Locations, France

Status
Completed
 
Locations

Investigative Site

Many Locations, Indonesia

Status
Completed
 
Locations

Investigative Site

Many Locations, Jordan

Status
Completed
 
Locations

Investigative Site

Many Locations, Netherlands

Status
Completed
 
Locations

Investigative Site

Many Locations, Philippines

Status
Completed
 
Locations

Investigative Site

Many Locations, Pakistan

Status
Completed
 
Locations

Investigative Site

Many Locations, Saudi Arabia

Status
Completed
 

Trial Design